Golia Pernicka, Jennifer S. https://orcid.org/0000-0002-1076-7948
Kim, Tae-Hyung
Nougaret, Stephanie
Bates, David D. B.
El Homsi, Maria
Louis Fuqua, J. III
Gangai, Natalie
Horvat, Natally
Pappou, Emmanouil
Paroder, Viktoriya
Widmar, Maria
Petkovska, Iva
Gollub, Marc J.
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
Article History
Received: 29 July 2025
Revised: 8 October 2025
Accepted: 26 October 2025
First Online: 14 November 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Jennifer S. Golia Pernicka, MD, from Memorial Sloan Kettering Cancer Center.
: The authors of this manuscript declare relationships with the following companies: Dr. Natally Horvat received lecture honoraria from Bayer (September 2022) and from Guerbet (May 2024). Dr. Horvat also served as a clinical consultant advisor for Guerbet (February 2023), received travel support from Guerbet (February 2023 and May 2024) and received writing support from Guerbet (March 2025). The remaining authors declare no conflict of interest.
: One of the authors, Stephanie Nougaret, MD, PhD, from the Montpellier Cancer Institute, Montpellier, France, has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained from Memorial Sloan Kettering Cancer Center.
: None.
: